¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Infection following immunization"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • aerosol infection
    ºÐ¹«°¨¿°
  • airborne infection
    °ø±â¸Å°³°¨¿°
  • anaerobic infection
    ¹«»ê¼Ò±Õ°¨¿°, Çø±â±Õ°¨¿°
  • community infection
    Áö¿ª°¨¿°
  • concurrent infection
    µ¿½Ã°¨¿°
  • contact infection
    Á¢Ã˰¨¿°
  • contagious infection
    Á¢Ã˰¨¿°, Á¢ÃËÀü¿°
  • cross infection
    ±³Â÷°¨¿°
  • cryptogenic infection
    Àẹ°¨¿°
  • defective infection
    °á¼Õ°¨¿°
  • droplet infection
    ºñ¸»°¨¿°
  • dust infection
    ¸ÕÁö°¨¿°
  • disseminated infection
    ÆÄÁ¾°¨¿°
  • double infection
    Áߺ¹°¨¿°
  • exogenous infection
    ¿ÜÀΰ¨¿°
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • systemic infection
    Àü½Å°¨¿°
  • vaginal infection
    Áú°¨¿°
  • wound infection
    »ó󰨿°
  • infection route
    °¨¿°°æ·Î
  • infection source
    °¨¿°¿ø, Àü¿°¿ø
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • apparent infection
    Áõ»ó°¨¿°
  • arthropod-borne infection
    ÀýÁöµ¿¹°¸Å°³°¨¿°
  • asymptomatic infection
    ¹«Áõ»ó°¨¿°
  • community infection
    Áö¿ª°¨¿°
  • concurrent infection
    µ¿½Ã°¨¿°
  • contact infection
    Á¢Ã˰¨¿°
  • contagious infection
    Á¢Ã˰¨¿°
  • cross infection
    ±³Â÷°¨¿°
  • cryptogenic infection
    Àẹ°¨¿°
  • hospital infection control
    º´¿ø°¨¿°°ü¸®
  • infection cycle
    °¨¿°»ç, °¨¿°°í¸®
  • laboratory infection control
    °Ë»ç½Ç°¨¿°°ü¸®
  • nosocomial infection control
    ¿ø³»°¨¿°°ü¸®
  • defective infection
    °á¼Õ°¨¿°
  • descending infection
    ÇÏÇà°¨¿°
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Gag antigen in HIV infection
    HIV °¨¿°ÀÇ gag Ç׿ø
  • HIV infection
    HIV °¨¿°
  • HIV infection diagnosis
    HIV °¨¿°Áø´Ü
  • Hemophilus infection
    Çì¸ðÇʷ罺°¨¿°, È£Ç÷±Õ°¨¿°.
  • Infection
    °¨¿°(Êïæø)
  • Klebsiella infection
    Ŭ·¹ºê½Ã¿¤¶ó °¨¿°(Áõ).
  • Marburg virus infection
    ¸¶¸£ºÎ¸£±× ¹ÙÀÌ·¯½º °¨¿°.
  • Marburg virus infection
    ¸¶¸£ºÎ¸£±× ¹ÙÀÌ·¯½º °¨¿°.
  • Marburg virus infection
    ¸¶¸£ºÎ¸£±× ¹ÙÀÌ·¯ ½º°¨¿°.
  • abnormality by infection
    °¨¿°±âÇü
  • abortive infection
    ºÒ¹ß°¨¿°, ºÎÀü°¨¿°
  • abortive infection
    ºÒÇö¼º°¨¿°(ÝÕúéàõÊïæø).
  • adenovirus infection
    ¾Æµ¥³ë¹ÙÀÌ·¯½º°¨¿°.
  • aerial infection = airborne i.
    °ø±â°¨¿°(ÍöѨÊïæø)
  • aerial infection =air borne i.
    °ø±â°¨¿°(ÍöѨÊïæø), ÈíÀÔ°¨¿°(ýåìýÊïæø).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • oral immunization
    °æ±¸¸é¿ª(¹ý)(ÌèÏ¢Øóæ¹Ûö).
  • oral immunization
    °æ±¸¸é¿ª(¹ý)(Ë­Ë´ËÎËçËÑ).
  • passive immunization
    ¼öµ¿¸é¿ª(áôÔÑØóæ¹).
  • prophylactic immunization
    ¿¹¹æÁ¢Á¾
  • abnormality by infection
    °¨¿°±âÇü
  • abortive infection
    ºÒÇö¼º°¨¿°(ÝÕúéàõÊïæø).
  • abortive infection
    ºÒ¹ß°¨¿°, ºÎÀü°¨¿°
  • adenovirus infection
    ¾Æµ¥³ë¹ÙÀÌ·¯½º°¨¿°.
  • aerial infection = airborne i.
    °ø±â°¨¿°(ÍöѨÊïæø)
  • aerial infection =air borne i.
    °ø±â°¨¿°(ÍöѨÊïæø), ÈíÀÔ°¨¿°(ýåìýÊïæø).
  • aerobic infection
    È£±â±Õ(¼º) °¨¿°(¡­Êïæø).
  • aerosol infection
    ºÐ¹«°¨¿°
  • air borne infection
    °ø±â°¨¿°, ÈíÀÔ°¨¿°.
  • air-borne infection
    °ø±â¸Å°³°¨¿°
  • anaerobic infection
    Çø±â¼º °¨¿°<Àü¿°>(¡­àõÊïæø<îîæø>).
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • source of infection
    °¨¿°¿ø
  • spurious infection
    °ÅÁþ°¨¿°
  • zoonotic infection
    Àμö°øÅë°¨¿°
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • puerperal infection
    »ê¿å°¨¿°
  • pyogenic infection
    È­³ó¼º°¨¿°
  • secondary infection
    ÀÌÂ÷°¨¿°, ¼Ó¹ß°¨¿°
  • silent infection
    ¹«Áõ»ó°¨¿°
  • staphylococcal infection
    Æ÷µµ±¸±Õ°¨¿°
  • surgical infection
    ¿Ü°úÀû°¨¿°
  • systemic infection
    Àü½Å¼º°¨¿°(Áõ)
  • viral infection
    ¹ÙÀÌ·¯½º°¨¿°
  • water-borne infection
    ¼öÀμº°¨¿°, ¼öÀμºÀü¿°
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
DPI daily permissible intake; days post inoculation; dietary protein intake; diphtheria-pertussis immuni...
EPI echo planar imaging; electronic portal imaging; Emotion Profile Index; epilepsy; epinephrine; epithe...
immun immune, immunity, immunization
IR drop of voltage across a resistor produced by a current; ileal resection; immune response; immunizat...
YFI yellow fever immunization
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
NID National Immunization Day
NIS National Immunization Survey
UTI 3-urinary tract infection
hpi 9h post infection
ARI Acute Respiratory Infection
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • consecutive infection
    ¼Ó¹ß¼º °¨¿°
  • contact infection
    Á¢ÃË °¨¿°
    º¸±ÕÀÚ, ¶Ç´Â º´¿øÃ¼°¡ ºÎÂøÇÑ ÀǺ¹, ¹°Ç° µî¿¡ Á÷Á¢ ´ê¾Æ ÇǺγª Á¡¸·À¸·Î °¨¿°µÇ´Â Àü¿°º´ÀÇ ÀüÆÄ ¾ç½Ä. ÀÓÁú, ¸Åµ¶, Æ®¶óÄÚ¸¶ µîÀÌ ´ëÇ¥Àû ÁúȯÀÌ´Ù. ȯÀÚ³ª º¸±ÕÀÚÀÇ º´¿øÃ¼°¡ ±âħ, Àçä±â, ´ëÈ­ µîÀ» ÅëÇÏ¿© »ç¶÷ÀÇ ÄÚ³ª ¸ñ±¸¸ÛÀÇ Á¡¸·¿¡ ºñ»ê, ºÎÂøÇÏ¿© °¨¿°À» ÀÏÀ¸Å°´Â ºñ¸» °¨¿°µµ Á¢ÃË °¨¿°¿¡ Æ÷ÇÔ½ÃŲ´Ù. ÀÎÇ÷翣ÀÚ, Æó°áÇÙ µîÀÌ ÀÌ¿¡ ¼ÓÇÑ´Ù.
  • Coxsackie virus infection
    ÄÛ»çŰ ¹ÙÀÌ·¯½º °¨¿°
  • cytomegalovirus infection
    °Å´ë ¼¼Æ÷ ¹ÙÀÌ·¯½º °¨¿°
  • Denal infection
    Ä¡¾Æ °¨¿°
  • dental focal infection
    Ä¡¾Æ Á᫐ °¨¿°
    ±¹¼ÒÀûÀ¸·Î Á¡Ã³·³ »ý±ä Ä¡¾Æ °¨¿°.
  • descending infection
    ÇÏÇà °¨¿°
  • dormant infection
    Àẹ °¨¿°, ÀáÀç °¨¿°, ÈÞ¸é °¨¿°
  • double infection
    Áߺ¹ °¨¿°
  • ECHO virus infection
    ¿¡ÄÚ ¹ÙÀÌ·¯½º °¨¿°
  • enteral infection
    Àå°ü °¨¿°
  • enterobacter infection
    ¿£Å׷ιÚÅ׸£ °¨¿°
  • enterovirus infection
    Àå ¹ÙÀÌ·¯½º °¨¿°
  • erysipelothrix infection
    ´Üµ¶ °¨¿°
  • focal infection
    ÃÊÁ¡ °¨¿°
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
hepatitis b immunization Hepatits B (hep B) vaccine gives prolonged protection, but 3 shots over a half year are usually required. In the u.s., all infants receive hep b vaccine. Two vaccines (engerix-b, and recombivax-hb) are available in the us. The first dose of hep b vaccine is frequently given while the newborn is in the hospital or at the first doctor visit following birth. The second dose is given about 30 days after the initial dose. A booster dose is performed approximately six months later. Babies born to mothers testing positive for hep b receive, in addition, hbig (hep b immune globulin) for prompt protection. Older children (11-12 years) are advised to receive a hep b booster as are adults in high-risk situations including healthcare workers, dentists, intimate and household contacts of patients with chronic hep b infection, male homosexuals, individuals with multiple sexual partners, dialysis patients, iv drug users, and recipients of repeated transfusions. Healthcare workers accidentally exposed to materials infected with hep b (such as needle sticks), and individuals with known sexual contact with hep b patients are usually given both hbig and vaccine to provide immediate and long term protection.
(12 Dec 1998)
hib immunization This vaccine is to prevent disease caused by the haemophilus influenzae type b (hib) bacteria. The h. Influenzae (h. Flu) bacteria can cause a range of serious diseases including meningitis with potential brain damage and epiglottitis with airway obstruction poisoning. The hib vaccine is usually given at 2, 4 and 6 months of age. A final booster is given at 12-15 months of age. Hib vaccine rarely causes severe reactions.
(12 Dec 1998)
dpt immunization DPT immunization protects from diphtheria, pertussis (whooping cough), and tetanus and is given in a series of 5 shots at 2, 4, 6, 18 months of age and 4-6 years of age. Thanks to vaccination programs, these diseases have become less common. However, there are still unvaccinated individuals capable of carrying and passing diphtheria and pertussis to others who are not vaccinated. Tetanus bacteria are prevalent in natural surroundings, such as contaminated soil. See also DTaP immunization.
(12 Dec 1998)
dtap immunization Like DPT, DTaP protects from diphtheria, pertussis (whooping cough) and tetanus. DTaP is the same as DTP, except that it contains only acellular pertussis vaccine which is thought to cause fewer of the minor reactions associated with immunization and is also probably less likely to cause the more severe reactions occasionally seen following pertussis vaccination. DTaP is currently recommended only for the shots given at 18 months and 4-6 years of age.
(12 Dec 1998)
dt immunization DT (diphtheria and tetanus) vaccine does not protect from pertussis and is usually reserved for individuals who have had a significant adverse reaction to a DPT shot or who have a personal or family history of a seizure disorder or brain disease.
(12 Dec 1998)
immunization <immunology> A process that increases an organisms reaction to antigen and therefore improves its ability to resist or overcome infection.
<technique> A technique used to induce immune resistance to a specific disease in humans (or other mammals) by exposing the individual to an antigen in order to raise antibodies to that antigen.
(13 Oct 1997)
immunization, anthrax A series of six shots over six months and booster shots annually, the anthrax vaccine now in use in the usa was first developed in the 1950s and approved by the food and drug administration for general use in 1970. It is produced by the michigan biologic products institute of michigan's department of health and is given routinely to veterinarians and others working with livestock. In december, 1997 it was announced that all us military would receive the vaccine, as do the military in the uk and russia, the reason being concern that anthrax might be used in biologic warfare.
(12 Dec 1998)
immunization, chickenpox This vaccine prevents the common disease known as chickenpox (varicella zoster). While chickenpox is often considered a trivial illness, it can cause significant lost time on the job and in school and have serious complications including ear infections, pneumonia, and infection of the rash with bacteria, inflammation of the brain (encephalitis) leading to difficulty with balance and coordination (cerebellar ataxia), damaged nerves (palsies), and reye's syndrome, a potentially fatal complication. The vaccination requires only one shot given at about a year of age. If an older person has not had chickenpox, the shot may be given at any time. There have been few significant reactions to the chickenpox vaccine. All children, except those with a compromised immune system, should have the vaccination.
(12 Dec 1998)
immunization, children's In the United States, it is recommended that all children receive vaccination against: hepatitis b diphtheria, tetanus, pertussis haemophilus influenzae type b (hib) poliovirus measles, mumps, rubella varicella zoster virus (chickenpox). Every child in the u.s. Should have these vaccinations except when there are special circumstances and the child's doctor advises specifically against a vaccination.
(12 Dec 1998)
immunization, dpt DPT immunization protects from diphtheria, pertussis (whooping cough), and tetanus and is given in a series of 5 shots at 2, 4, 6, 18 months of age and 4-6 years of age. Thanks to vaccination programs, these diseases have become less common. However, there are still unvaccinated individuals capable of carrying and passing diphtheria and pertussis to others who are not vaccinated. Tetanus bacteria are prevalent in natural surroundings, such as contaminated soil. See also immunization, dtap.
(12 Dec 1998)
immunization, dt DT (diphtheria and tetanus) vaccine does not protect from pertussis and is usually reserved for individuals who have had a significant adverse reaction to a dpt shot or who have a personal or family history of a seizure disorder or brain disease.
(12 Dec 1998)
immunization, dtap Like DPT, DTaP protects from diphtheria, pertussis (whooping cough) and tetanus. Dtap is the same as dtp, except that it contains only acellular pertussis vaccine which is thought to cause fewer of the minor reactions associated with immunization and is also probably less likely to cause the more severe reactions occasionally seen following pertussis vaccination. Dtap is currently recommended only for the shots given at 18 months and 4-6 years of age.
(12 Dec 1998)
immunization, flu The flu (influenza) vaccine is recommended for persons at high risk for serious complications from influenza infection, including everyone 65 or over; people with chronic diseases of the heart, lung or kidneys, diabetes, immunosuppression, or severe forms of anaemia; residents of nursing homes and other chronic-care facilities, children and teenagers taking aspirin therapy (and who may therefore be at risk for developing reye syndrome after an influenza infection), and those in close or frequent contact with anyone at high risk. Persons with an allergy to eggs should not receive influenza vaccine.
(12 Dec 1998)
immunization, german measles See Immunization, MMR.
(12 Dec 1998)
immunization, haemophilus influenzae type b See immunization, hib.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á